EcoDrugPlus

Leukotriene B4 Receptor 2a

Ensembl ID : ENSAOCG00000001108
Gene Symbol: LTB4R2A
1 Cross references
159 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSAOCG00000002164
Gene Symbol: LTB4R2B
1 Cross references
167 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSAOCG00000021150
Gene Symbol: LOC111577894
4 Cross references
201 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSAOCG00000016351
Gene Symbol: KDM1A
3 Cross references
214 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSAOCG00000003962
Gene Symbol: LOC111577858
3 Cross references
208 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSAOCG00000007938
Gene Symbol: LOXL2
3 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 2-Like

Ensembl ID : ENSAOCG00000015797
Gene Symbol: LOC111575718
2 Cross references
199 Possible Orthologues:

Macrophage Migration Inhibitory Factor-Like

Ensembl ID : ENSAOCG00000009067
Gene Symbol: LOC111583658
3 Cross references
231 Possible Orthologues:

Macrophage Migration Inhibitory Factor-Like

Ensembl ID : ENSAOCG00000013649
Gene Symbol: LOC111578098
3 Cross references
233 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSAOCG00000020104
Gene Symbol: MST1R
2 Cross references
194 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSAOCG00000002863
Gene Symbol: LOC111574952
2 Cross references
196 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSAOCG00000021020
Gene Symbol: LOC111569809
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).